Skip to content

Clinical trials

Completed Phase 4 Bacteremia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bacteremia Phase: Phase 4 Status: Completed Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20061
20071
20101
20124
20132
20151
20161
20191
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
Forest Laboratories1
Hopital Lariboisière1
Instituto do Coracao1
Javeriana University1
McGill University Health Centre/Research Institute of the McGill University Health Centre1
Murdoch Childrens Research Institute1
Pfizer1
Satellite Healthcare1
Sharp HealthCare1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bacteremia16
Sepsis5
Infections3
Catheter-Related Infections2
Periodontitis2
Bacterial Infections1
Fungemia1
Gingivitis1
Gram-Negative Bacterial Infections1
Gram-Positive Bacterial Infections1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.